Personalized phage therapy to fight AMR infections
Our personalized phage therapy solutions were tested in >100 critically ill patients with a success rate > 70% and no serious side effects.
Fast selection of therapeutic phages at the hospital – Phages pre-produced and delivered within 24 to 48h to the patient
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Validation
- Market entry
- Research
- Development
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- CARB-X
- FIND
- GARDP
- REPAIR
- OTHER / NA
Infectious disease area:
- UTI
- BSI
- RTI
- SSTI
- IAI
- SSI
- STI
- GII
- CNSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
We fight AMR infections with personalized phage therapy solutions (automated diagnostic tool with a library of phages that we can produce).
N.A.